- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
- You can view the full 3M Ratings Report.
M&A may dominate headlines, but investors need to watch earnings as well, says Jim Cramer.
India drugmaker Intas will pay about $770 million for the UK and Ireland generics assets.